ALDX
Price:
$4.85
Market Cap:
$288.82M
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for ...[Read more]
Industry
Biotechnology
IPO Date
2014-05-02
Stock Exchange
NASDAQ
Ticker
ALDX
According to Aldeyra Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Aldeyra Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ALDX's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Aldeyra Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Aldeyra Therapeutics, Inc. (ALDX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Aldeyra Therapeutics, Inc.’s Dividend Yield is less than Tarsus Pharmaceuticals, Inc. (0%), less than LianBio (3.01%), less than Travere Therapeutics, Inc. (0%), less than Eton Pharmaceuticals, Inc. (0%), less than Viridian Therapeutics, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Structure Therapeutics Inc. (0%), less than Blueprint Medicines Corporation (0%), less than 89bio, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than HOOKIPA Pharma Inc. (0%), less than Phathom Pharmaceuticals, Inc. (0%), less than Lyra Therapeutics, Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than BioLineRx Ltd. (0%), less than Ardelyx, Inc. (0%), less than Lexicon Pharmaceuticals, Inc. (0%), less than Seres Therapeutics, Inc. (0%), less than ImmunityBio, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $1.84B | |
3.01% | $34.47M | |
0% | $1.59B | |
0% | $290.14M | |
0% | $1.60B | |
0% | $491.80M | |
0% | $1.91B | |
0% | $5.98B | |
0% | $1.03B | |
0% | $57.64M | |
0% | $180.51M | |
0% | $1.38B | |
0% | $20.76M | |
0% | $638.64M | |
0% | $12.37M | |
0% | $730.17M | |
0% | $38.31M | |
0% | $1.26B | |
0% | $312.11M | |
0% | $131.23M | |
0% | $3.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aldeyra Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aldeyra Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Aldeyra Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Aldeyra Therapeutics, Inc. (ALDX)?
What is the highest Dividend Yield for Aldeyra Therapeutics, Inc. (ALDX)?
What is the 3-year average Dividend Yield for Aldeyra Therapeutics, Inc. (ALDX)?
What is the 5-year average Dividend Yield for Aldeyra Therapeutics, Inc. (ALDX)?
How does the current Dividend Yield for Aldeyra Therapeutics, Inc. (ALDX) compare to its historical average?